Last month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP with the goal of making the drug available in low and middle-income countries.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/32B2Dmh
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» India may have to wait longer for Pfizer, GSK's Covid drugs
https://ift.tt/eA8V8J
No comments:
Post a Comment